Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Number of users of COPD and asthma medication in Norway 2007-2017

Number of users of COPD and asthma medication in Norway from 2007 to 2017 (per 100,000 inhabitants)

by F. Norrestad, last edited Apr 18, 2019
Number of users of COPD and asthma medication in Norway 2007-2017 This statistic shows the number of users of COPD and asthma medication in Norway from 2007 to 2017. The number of users was increasing over the period. In 2017, the number of users peaked at 111 individuals per hundred thousand.
Show more

Number of users of COPD and asthma medication in Norway from 2007 to 2017 (per 100,000 inhabitants)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Asthma in the U.S."
  • Prevalence
The most important statistics
  • Asthma attacks
  • Deaths
  • Regions and states
  • Doctors and hospitals
  • Medication
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.